• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Masimo has more potential suitors for consumer audio business

Masimo has more potential suitors for consumer audio business

August 16, 2024 By Chris Newmarker

This is the logo of Masimo.Masimo (Nasdaq: MASI) announced today it now has multiple potential suitors for its consumer audio business. 

The San Diego–based digital health pioneer previously disclosed that an undisclosed potential joint venture partner had offered a $850–950 million purchase price for a majority stake in its consumer business. Masimo officials planned to negotiate for a better price. In an SEC Form 8-K filed today, Masimo said the exclusivity period in the negotiations had ended, but discussions continued.

Meanwhile, Masimo, in the SEC form, also disclosed that it has separately received unsolicited inbound requests from other potential acquirers of its consumer audio business. Masimo, through its financial advisor Morgan Stanley, plans to begin discussions with the other parties.

The company said in the 8-K: “Masimo’s board of directors will seek and evaluate the optimal value-maximizing structure of the separation of Masimo’s consumer business, including a joint venture, spin-off of the consumer business into a new public company or complete sale of the consumer audio business, either with or without the consumer health business. In all cases, Masimo would retain its professional healthcare and telehealth/telemonitoring products.”

BTIG analysts kept their Buy rating on MASI shares amid the news. MASI shares were up nearly 1.5% to $123.38 apiece by midday trading today. MassDevice‘s MedTech 100 Index was up slightly.

Under pressure from activist investor Politan Capital Management, the maker of pulse oximeters, wearable health trackers, and other health monitoring devices has been looking at options to split off its consumer business, created in 2022 through its $1.025 billion acquisition of Viper Holdings. Viper was the parent company of Sound United and its high-end audio and home theater systems.

In July, Masimo announced that it was delaying its shareholders meeting until Sept. 19, 2024 as it sued Politan over what it claimed were “material misstatements” in heated proxy fight communications. Politan is seeking CEO Joe Kiani’s ouster a year after it won a heated fight for two board seats.

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Mergers & Acquisitions, Patient Monitoring Tagged With: Masimo

More recent news

  • Massachusetts Life Sciences Center offers grants to lower medtech commercial risk
  • The 10 largest medical device companies
  • CSL to drop Terumo for Haemonetics in US plasma collection supply deal
  • How 5 medtech CEOs design for access
  • Butterfly Network to chase ultrasound brain-computer interfaces with newcomer Bridge Neurotech

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy